RESUMO
BACKGROUND: Given the high-risk nature and nurse sensitivity of chemotherapy infusion and extravasation prevention, as well as the absence of an industry benchmark, a group of nurses studied oncology-specific nursing-sensitive indicators. â©. OBJECTIVES: The purpose was to establish a benchmark for the incidence of chemotherapy extravasation with vesicants, irritants, and irritants with vesicant potential.â©. METHODS: Infusions with actual or suspected extravasations of vesicant and irritant chemotherapies were evaluated. Extravasation events were reviewed by type of agent, occurrence by drug category, route of administration, level of harm, follow-up, and patient referrals to surgical consultation.â©. FINDINGS: A total of 739,812 infusions were evaluated, with 673 extravasation events identified. Incidence for all extravasation events was 0.09%.
Assuntos
Antineoplásicos/efeitos adversos , Institutos de Câncer/organização & administração , Extravasamento de Materiais Terapêuticos e Diagnósticos/epidemiologia , Neoplasias/tratamento farmacológico , Antineoplásicos/administração & dosagem , Humanos , Incidência , Neoplasias/enfermagemRESUMO
OBJECTIVES: To provide a comprehensive review of the acute complications that occur during the first 100 days post stem cell transplant (SCT). DATA SOURCES: Research studies, book chapters, websites, and articles. CONCLUSION: Even though the outcomes for SCT continue to improve, the complications seen in the first 100 days post transplant are a significant cause of mortality. Astute nursing assessment with resultant early intervention improves treatment-related mortality. IMPLICATIONS FOR NURSING PRACTICE: Because SCT patients are seen in every oncology care setting, knowledge of these acute complications is essential to helping the nurse care for and educate SCT recipients.
